Company intelligence / Profile preview

Matias Healthcare

Indore, Madhya Pradesh, India

Ownership: Private
Development stage: Other

Overview

Matias Healthcare markets over 150 brands (400+ SKUs), including nutraceuticals and pharma products spanning neurology, orthopaedics, gynaecology, pain, cardiology, and psychiatry. All products are manufactured in WHO GMP-certified facilities; the company partners with third-party manufacturing organizations and does not appear to perform clinical trials itself.

Therapeutic areas: RheumatologyMetabolic DisordersPsychiatryCardiovascularNeurologyWomen's Health
Modalities: Small moleculeNutraceutical
Industry: Biotech

Partnerships

AKUM LAB LTDSYNOKEM LAB LTDBIO DEALS LTDWIND LAST LTD

Beyond the preview

Go deeper on Matias Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matias Healthcare.

Explore the full profile